bla KPC RNA expression correlates with two transcriptional start sites but not always with gene copy number in four genera of gram-negative pathogens

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 8, 2011, Pages 3936-3938

  Roth, Amanda L ^a   Kurpiel, Philip M ^a   Lister, Philip D ^a   Hanson, Nancy D ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM; CARBAPENEMASE; RNA;

ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BLA GENE; CORRELATION ANALYSIS; GENE DOSAGE; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; KLEBSIELLA PNEUMONIAE; MOLECULAR CLONING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; DNA FINGERPRINTING; DNA, BACTERIAL; ENTEROBACTER CLOACAE; ESCHERICHIA COLI K12; GENE DOSAGE; GRAM-NEGATIVE BACTERIA; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION INITIATION SITE;

EID: 79960327653     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01509-10     Document Type: Article

References (24)

1. Alba, J., Y. Ishii, K. Thomson, E. S. Moland, and K. Yamaguchi. 2005. Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing beta-lactamase. Antimicrob. Agents Chemother. 49:4760-4762.
2. Bradford, P. A., et al. 2004. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin. Infect. Dis. 39: 55-60.
3. Bratu, S., et al. 2005. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch. Intern. Med. 165:1430-1435.
4. Bratu, S., et al. 2005. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob. Agents Chemother. 49:3018-3020.
5. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; 21st informational supplement M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Clinical and Laboratory Standards Institute. 2011. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 8th ed. Approved standard M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
7. KPC- containing Klebsiella pneumoniae isolates detected in different institutions in the eastern U.S.A. J. Antimicrob. Chemother. 63:427-437.
8. KPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital. Antimicrob. Agents Chemother. 53: 1998-2004.
9. Kitchel, B., et al. 2010. Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 54:4201-4207.
10. Landman, D., S. Bratu, and J. Quale. 2009. Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae. J. Med. Microbiol. 58:1303-1308.
11. Lisser, S., and H. Margalit. 1993. Compilation of E. coli mRNA promoter sequences. Nucleic Acids Res. 21:1507-1516. (Pubitemid 23146313)
12. T) method. Methods 25:402-408.
13. Navon-Venezia, S., et al. 2006. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob. Agents Chemother. 50:3098-3101.
14. Record, M. T., W. S. Reznikoff, M. L. Craig, K. L. McQuade, and P. J. Schlax. 1996. Escherichia coli RNA polymerase (E sigma 70), promoter, and the kinetics of the steps of transcription initiation, p. 792-821. In F. C. Neidhardt (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed., vol. 1. ASM Press, Washington, DC.
15. Reisbig, M. D., A. Hossain, and N. D. Hanson. 2003. Factors influencing gene expression and resistance for Gram-negative organisms expressing plasmid-encoded ampC genes of Enterobacter origin. J. Antimicrob. Chemother. 51:1141-1151.
16. Roth, A. L., et al. 2009. 49th Intersci. Conf. Antimicrob. Agents Chemother., abstr. C2-665.
17. Roth, A. L., et al. 2010. 50th Intersci. Conf. Antimicrob. Agents Chemother., abstr. C2-1158.
18. Schmidtke, A. J., and N. D. Hanson. 2006. Model system to evaluate the effect of ampD mutations on AmpC-mediated beta-lactam resistance. Antimicrob. Agents Chemother. 50:2030-2037.
19. Skulj, M., et al. 2008. Improved determination of plasmid copy number using quantitative real-time PCR for monitoring fermentation processes. Microb. Cell Fact. 7:6.
20. Spaink, H. P., R. J. H. Okker, C. A. Wijffelman, E. Pees, and B. J. J. Lugtenberg. 1987. Promoters in the nodulation region of the Rhizobium leguminosarum sym plasmid pRJ1JI. Plant Mol. Biol. 9:27-39.
21. Tenover, F. C., et al. 2006. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg. Infect. Dis. 12: 1209-1213.
22. Wolter, D. J., et al. 2009. Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4. Antimicrob. Agents Chemother. 53:557-562.
23. Yigit, H., et al. 2001. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:1151-1161.
24. Zhang, R., L. Yang, J. C. Cai, H. W. Zhou, and G. X. Chen. 2008. High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression. J. Med. Microbiol. 57:332-337.